Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hemangioma × Sodium Chloride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 30 Neoplasms 10 Pain, Postoperative 9 Lung Neoplasms 9 Colorectal Neoplasms 9 Pancreatic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Brain Neoplasms 7 Stomach Neoplasms 6 Prostatic Neoplasms 5 Melanoma 5 Ovarian Neoplasms 4 Leiomyoma 4 Hemorrhage 4 Glioblastoma 4 Colonic Neoplasms 4 Skin Neoplasms 3 Recurrence 3 Rectal Neoplasms 3 Neoplasm Metastasis 3 Nasopharyngeal Carcinoma 3 Myoma 3 Lymphoma, Non-Hodgkin 3 Leukemia, Myeloid, Acute 3 Head and Neck Neoplasms 3 Fatigue 3 Delirium 3 Chronic Pain 3 Agnosia 3 Uterine Cervical Neoplasms 2

Interventions

Propranolol 8 Timolol 5 Prednisone 3 Prednisolone 3 Adrenergic beta-Antagonists 3 Solutions 2 Saline Solution 2 Adrenal Cortex Hormones 2 prednisolone phosphate 1 Vincristine 1 Tomography, Optical Coherence 1 Steroids 1 Sodium Chloride 1 Sirolimus 1 Population Groups 1 Ointments 1 Nadolol 1 Mupirocin 1 Methylprednisolone 1 Leuprolide 1 Lasers, Semiconductor 1 Lasers, Dye 1 Imiquimod 1 Gels 1 Everolimus 1 Bleomycin 1 Atenolol 1 Acebutolol 1 68Ga-1,4,7-triazacyclononane-N,N',N''-triacetic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01685398 2023-09-21

Topical Timolol for Superficial Infantile Hemangioma

Mahidol University

Phase 3 Completed

Hemangioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡